Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery
© Panjkovich and Daura; licensee BioMed Central Ltd. 2010
Received: 2 January 2010
Accepted: 31 March 2010
Published: 31 March 2010
With the classical, active-site oriented drug-development approach reaching its limits, protein ligand-binding sites in general and allosteric sites in particular are increasingly attracting the interest of medicinal chemists in the search for new types of targets and strategies to drug development. Given that allostery represents one of the most common and powerful means to regulate protein function, the traditional drug discovery approach of targeting active sites can be extended by targeting allosteric or regulatory protein pockets that may allow the discovery of not only novel drug-like inhibitors, but activators as well. The wealth of available protein structural data can be exploited to further increase our understanding of allosterism, which in turn may have therapeutic applications. A first step in this direction is to identify and characterize putative effector sites that may be present in already available structural data.
We performed a large-scale study of protein cavities as potential allosteric and functional sites, by integrating publicly available information on protein sequences, structures and active sites for more than a thousand protein families. By identifying common pockets across different structures of the same protein family we developed a method to measure the pocket's structural conservation. The method was first parameterized using known active sites. We characterized the predicted pockets in terms of sequence and structural conservation, backbone flexibility and electrostatic potential. Although these different measures do not tend to correlate, their combination is useful in selecting functional and regulatory sites, as a detailed analysis of a handful of protein families shows. We finally estimated the numbers of potential allosteric or regulatory pockets that may be present in the data set, finding that pockets with putative functional and effector characteristics are widespread across protein families.
Our results show that structurally conserved pockets are a common feature of protein families. The structural conservation of protein pockets, combined with other characteristics, can be exploited in drug discovery procedures, in particular for the selection of the most appropriate target protein and pocket for the design of drugs against entire protein families or subfamilies (e.g. for the development of broad-spectrum antimicrobials) or against a specific protein (e.g. in attempting to reduce side effects).
Molecular processes in the living cell are coordinated and executed under tight regulation. Proteins play a fundamental role in almost all biological processes, and their overall activity is regulated at different levels . At a first level, the concentration of a particular protein in the cell is regulated through its synthesis rate (gene expression) and its degradation rate. At another level, mechanisms act on the protein molecule itself through covalent modifications or non-covalent binding of small ligands or other molecules. These regulatory mechanisms are not only essential for the proper functioning of the molecular processes that maintain life, but are also responsible for cross-signaling and regulation processes between an organism and its environment.
Many metabolic enzymes, signalling proteins and transcription factors, among others, are regulated allosterically. Allosteric regulation has been studied for more than 50 years and it is considered the most powerful and common way to regulate protein activity . However, for most known cases of allosterism, the atomic details that explain the functional relationship between distant sites on the same protein molecule have not been elucidated [3, 4].
Many pharmaceutical compounds act through allosteric regulation, as seen in the case of paclitaxel (Paxol), a cancer therapeutic drug that regulates tubulin polymerization allosterically [5, 6]. Even though active sites represent the classic drug-target pocket (e.g. Aspirin and cyclooxygenase), allosteric sites present advantages over active sites in the context of drug design. Enzymatic activity usually involves charged transition states and the substrates are not always drug-like. Thus, orally active inhibitors that complement these sites can be very difficult to obtain. Moreover, allosteric sites may allow the discovery of not only novel drug-like inhibitors, but activators as well [2, 3].
In this context, predicting allosteric sites computationally is of great interest. Allosteric sites have been predicted using structural information  and phylogeny . Recently, methods have been developed in order to model or predict the relationship between allosteric and active sites [9–11]. These methods represent an important step forward in the understanding of allosterism. However, these studies are limited by the low quantity of readily available data on allosteric sites. As stated by Thornton and collaborators in their recent review , this is due in part to the lack of a formal database that organizes and stores knowledge on allosteric proteins and the corresponding mechanisms.
To unveil common patterns underlying allosterism, given that these exist, a large-scale study using structural and sequence data would be necessary. However, given the present scenario of scarce allosteric-site data, we decided to perform a large-scale analysis of protein ligand-binding pockets, as these represent potential locations of functional and allosteric or regulatory sites. Our approach is supported by the concept that besides naturally ocurring allosteric sites, serendipitous sites -having no natural ligand but effectively being an allosteric site given an appropriate ligand- may be of great pharmacological interest . Examples of previously unknown allosteric sites discovered on already solved protein structures [12, 13] support the idea that orphan or serendipitous allosteric sites exist which may lack a known natural effector, but provide an excellent opportunity for drug discovery approches such as virtual screening. Hardy and Wells also suggest that the large amount of 'crystallization artifacts' present in the Protein Data Bank (PDB) , such as ligands co-crystallized in unexpected binding sites, could hint the presence of previously unknown allosteric sites .
A large database of protein structures and associated small-molecule ligands is available  and has been used to predict ligand-binding sites by homology . However, small-molecule ligands are not always easy to co-crystallize and we did not want to limit our study to only such cases. In this context, ligand-binding sites can be computationally predicted from structure alone with reasonable accuracy [17–20]. To our knowledge, ligand-binding pockets as predicted directly from structure  have not been studied or characterized at large-scale yet, even though they represent the potential location of yet unknown effectors .
Functional pockets in proteins have been previously characterized in terms of their flexibility [21, 22], evolutionary conservation [21, 23] and electrostatic potential  and these characteristics have been used to predict their presence and location in the protein structure . Evolutionary conservation is a common characteristic of biologically functional sites. However, until now it has been exploited solely at the sequence level . Although sequence and structural conservation correlate, structure is closer to function and may be conserved even in the lack of a sequence-level signal . Despite this, to our knowledge, an approach based on the structural conservation of protein pockets has not been previously used. Here, we introduce a simple methodology to study pockets at the protein family level, consisting in the identification of pockets present in equivalent positions across different structures of the same protein family. To parameterize the method, we used protein pockets that matched known active sites, as these are well annotated [26, 27]. Once parameterized, we applied the method to all protein structures available in the PDB , leading to the identification of protein pockets for thousands of different protein families . Next, we compared the levels of structural conservation with other pocket characteristics estimated on the same protein families, such as sequence level conservation, backbone flexibility and electrostatic potential.
In the following sections we also discuss the results of this analysis for a small set of biological examples which illustrate the relevance of structural conservation in studying protein functional and regulatory sites. Finally, we perform an estimation of the amount of potentially paired regulatory and functional sites that may exist in the entire data set.
Results and Discussion
Initial structural data set
To acquire a large-scale perspective on the conservation of protein pockets, we gathered all available protein structures from the Protein Data Bank (PDB) . We applied a set of filtering criteria to ensure the quality and relevance of the structural data before grouping the structures by protein families, as defined by the Protein families database (Pfam) . To partially cope with the inherent bias present in the PDB, where proteins tend to be over- or under-represented , we selected a set of representative structures for each protein family (see Methods). The final data set covered 4,258 different Pfam protein families and was composed of a total of 22,312 distinct protein structures (maximum 95% sequence identity), on which we predicted the location of 167,648 putative ligand-binding pockets by means of the LIGSITEcs program .
Identifying equivalent pockets across different protein structures
Parameterization. Performance of the clustering algorithm when grouping known active sites.
Fixed distance value (Å)
% total active sites
% non active sites
Assessing the structural conservation of pockets on protein families
According to the histograms in this figure, the higher the coverage of the active site cluster the higher its frequency in the ensemble of families. This, which should be expected for pockets that are functionally relevant at the family level, is also applicable to the distribution of cluster 1 but not to those of clusters 2 and 3. Yet, the coverage distributions of clusters 2 and 3 suggest that they could be important at a sub-family level, remaining compatible with an allosteric function which may have different faces within the same protein family. In global terms, the average coverage of the first cluster or most conserved pocket of the 1,128 protein families analyzed is 85%. Of these 1,128 protein families, 398 (35%) show at least one pocket cluster that covers 100% of the protein-family representatives, while 884 (78%) present a pocket cluster that covers at least 75% of the protein family.
These results show that for the majority of the protein families analyzed there is at least one pocket with high levels of structural conservation. We expected a high frequency of conserved pockets among enzymes, but not all protein families in the data set have been annotated with a biological activity that is related to a pocket in the protein structure. A structurally conserved pocket whose biological function has not been described is an optimal candidate for further computational and experimental analysis. For example, in the context of drug design and discovery, the information on whether a pocket on the target protein is structurally conserved or not may be useful when designing a wide-spectrum or a specific drug, respectively, and in choosing the appropriate ligand-binding site for virtual screening. Clearly a pocket that is very well conserved at the structural level may not necessarily have functional properties but be the consequence of structural restraints common across the protein family. Nevertheless, it may still be of interest to explore its possible exploitation as a serendipitous allosteric site for a therapeutic application .
Before further exploring these possibilies, we analyzed the degree of correlation between structural conservation and other properties often used for the characterization of protein pockets, such as evolutionary conservation at the sequence level [18, 21, 23], protein flexibility [21, 22] and electrostatic potential . These parameters may be useful in distinguishing pockets that are conserved because of their biological function from pockets that are conserved because of structural restraints.
Comparison with other pocket characteristics
Biologically relevant residues tend to be conserved at the sequence level . In this context, the degree of conservation of the residues defining a protein cavity may be taken as a measure of the cavity's conservation [18–20]. The statistical significance of this measure can be then tested by comparing the levels of sequence conservation in the pocket and in the rest of the protein (see Methods).
One may argue that pocket clusters displaying high sequence and structural conservation may match biologically functional pockets across the protein family, while clusters displaying only structural conservation may often play a purely structural role. In relation to this, and giving the conservation percentages the right context, it should be noted that a large proportion of the protein families included in this analysis may not present a biological activity that is related to a particular pocket in the structure. Nevertheless, some pockets may be biologically relevant, despite a lack of sequence conservation. An example of this is given by L-lactate dehy-drogenase (LDH), for which the allosteric site  is very well conserved at the structural level (89.8%), but shows no signal of sequence conservation (0.0%) in this analysis. We describe the LDH case in further detail below.
As discussed above, pockets that are conserved at the structural level but have not been previously described as ligand-binding sites may be evaluated as potential orphan or serendipitous allosteric sites and targeted for drug discovery and design. The low sequence conservation we observed in many of the structurally conserved pockets indicates that even though the pocket is detected in the same location, the residues defining the pocket are not under direct evolutionary pressure and may vary in type. This variation in residue composition could aid the design of highly specific drugs that would bind only certain members of the protein family.
We performed the same distribution analysis for pocket clusters that included the largest amount of active sites in the corresponding protein families, with results displayed in the right panel of Figure 2. In this case, the largest population corresponds to high levels of both sequence and structural conservation, as expected, although numerous exceptions appear in this set as well. Some exceptions rise because not all members of a given Pfam protein family may be enzymatically active (e.g. Globin).
Note that the level of sequence conservation of each cluster is estimated from its member pockets and is independent of the weight of the cluster in the set of family-representative structures. A sequence conservation of 100% means that every single pocket in the cluster is significantly conserved at the sequence level, although the cluster may only cover half of the protein family, i.e. 50% structural conservation. This is also valid for the flexibility and electrostatic-potential analyses described below.
Protein function is fundamentally linked to dynamics. In this context, the properties of a protein's ligand-binding site are to an important extent a function of the site's flexibility, entropy being an essential component of the free energy of binding. Thus, relatively small changes in flexibility often have a large effect on ligand-binding affinites . Moreover, some allosteric sites regulate protein function by modifying the protein's flexibility upon ligand binding [2, 9, 33].
Flexibility may be estimated on a residue basis from structural B factors. This has been previously used, for example, to show that active sites tend to be more rigid than the rest of the enzyme structure [21, 22].
The lower panels of Figure 3 show a wide distribution of significantly rigid pockets. This means that within a family, the levels of flexibility for the same pocket may differ from structure to structure considerably. These results were expected to a certain level, since flexibility may vary under different experimental conditions of structure determination and it may as well be modified by the presence of bound ligands or other proteins . In the case of active site pocket clusters, the lower-right panel of Figure 3 displays a stronger signal for structural conservation than for rigidity.
Protein flexibility is a major issue for ligand virtual screening and design . Although key residues in active sites, such as those involved in catalysis, tend to be rigid [21, 22], they coexist with regions of high flexibility, which are necessary to allow for ligand exchange. When searching for other possible ligand-binding sites for the screening and design of effector molecules, one will usually target pockets that are sufficently flexible that binding will not be blocked by high free-energy barriers (involving conformational rearrangements) but at the same time sufficiently rigid that computational docking will be reliable and that there will not be a sizable entropic penalty due to a potentialy large loss of flexibility upon ligand binding (which would need to be compensated enthalpically for effective binding). The analysis shown here might provide a basis to select structurally conserved pockets with specific flexibility properties.
To complement the large-scale perspective presented above we analyzed a few protein families in more detail. The examples described below emphasize the relevance of structural conservation in the study of allosteric and functional protein pockets.
The active site in this protein matches pocket clusters 2 and 4. Both clusters are very well conserved at the sequence level with, respectively, 92.1% and 77.8% of the included pockets being significantly conserved. These active-site pockets are also well conserved at the structural level: cluster 2 appears on 75.5% of the representative structures while cluster 4 appears on 65.3% and, when considered together, at least one of them appears on 94% of the protein family. Interestingly, the pocket cluster with the highest structural conservation (cluster 1), corresponds to the allosteric site (Figure 5). In this case the allosteric cluster covers the majority of representative structures for this family (89.8%). However, the average sequence conservation signal is very low (-0.12) and we found none of the 51 pockets included in this cluster to be significantly conserved at the sequence level. This means that an evolutionary analysis based purely on sequence information would not find this site to be significally conserved, while the structure-based approach points it out as the most conserved pocket in this protein family.
The allosteric site cluster is remarkable in terms of flexibility as well, with 81.2% of included pockets being significantly rigid (see Methods). In the case of PDB entry [PDB:1LTH], there is a clear difference in the global flexibility values we calculated for the R (0.43) and T (-0.56) structures of the protein, corresponding to the active and inactive states, respectively. However, the allosteric site pocket shows consistently low values, -0.52 and -0.93 for R and T, respectively, with both pockets being significantly rigid according to the statistical test (p-values of 0.0008 and 0.0012, respectively). The active site in [PDB:1LTH] shows no significant differences in terms of flexibility when compared to the rest of the structure, although as expected, differences between the T and R states are also observed. The rigidity of the active site pockets through the whole family is not clear from the data, as 69.4% and 25.7% of the pockets are significantly rigid for clusters 2 and 4, respectively.
In the [PDB:1LTH] entry, the estimated electrostatic potential for the allosteric and active site have different values, with 1.22 and -8.09 kT/e, respectively, for the R state and similar values for the T state (1.36 and -5.73 kT/e respectively). This case matches the concept that active sites may bind more polar or charged molecules, while the allosteric site may bind more drug-like ligands . When averaging these values over the corresponding member pockets, the standard deviation is close in magnitude to the values obtained, being 2.04 kT/e for the allosteric site cluster and -3.73 kT/e for the active site cluster 2. As discussed above, the electrostatic potential estimations tend to vary largely from structure to structure and thus are hard to extrapolate across the different proteins in a family.
Briefly, in this protein family we found the active site to match expected characteristics of biologically relevant pockets, being very well conserved both in terms of sequence and structure. The allosteric site, despite being very well conserved in terms of structure, does not appear to be conserved at the sequence level.
ADP Ribosylation factor 1
Arf pocket clusters.
structural conservation (%)
sequence conservation (%)
Cluster 1 matches the pyrophosphate group of GDP and the Mg ion as displayed in Figure 6. This cluster covers 62.5% of the representative structures of this protein family and we found all of the included pockets to be significantly conserved at the sequence level. The numbers for cluster 3 are similar, as 100% of its pockets are significantly conserved at the sequence level and are detected on 81.3% of the representative structures of this protein family. This cluster matches the pyrimidine-imidazole part of GDP as displayed in Figure 6.
We do not know the biological function, if any, of the pockets represented by the rest of the clusters displayed in Figure 6. Although cluster 2 shows a high level of structural conservation covering 87.5% of the family, the pocket is not significantly conserved at the sequence level. Another interesting cluster is number 5, which appears on 93.8% of the structures and has a sequence conservation of 100%. This cluster is also rigid, with 60% of its pockets being significantly rigid, similarly to the clusters matching the allosteric site. It is interesting that cluster 4 shows almost half of its pockets to be significantly rigid and the other half to be significantly flexible as indicated by the values in Table 2. Initially we thought that this could be related to co-crystallized ligands affecting the flexibility of particular pockets through binding, but none of the analyzed structures presented a ligand in this position. We compared two structures corresponding to this family, namely PDB entry [PDB:1Z6X] (where the corresponding pocket is significantly flexible) and [PDB:1FZQ] (where the pocket was found to be sig-nificantly rigid). The rigid pocket in [PDB:1FZQ] was located next to an α-helix, while the same region in [PDB:1Z6X] lacked secondary structure presenting a loop-like conformation. It is remarkable that a pocket may be consistently found in two structures of the same family in a region with diverse secondary structure arrangements and levels of local backbone flexibility. Given that flexibility plays an important role in binding affinity , structurally conserved pockets may present distinct binding dynamics that can be exploited in the design of highly specific drugs.
Prediction of allosteric sites
Pairs of conserved distant pocket clusters, allosteric sites prediction.
Conservation thresholds (%)
# protein families
active site match
For example, we found such a pair of pocket clusters on the structures corresponding to the PIG-L Pfam family. One of theses structures ([PDB:1Q7T]) corresponds to MshB from Mycobacterium tuberculosis and is considered a potential therapeutic target . This protein lacks active site annotation in Pfam  or in the Catalytic Site Atlas . However, the group of Baker et al. localized the active site when determining the protein's structure . The active site predicted by Baker and co-workers matches cluster 2 in our predictions and is highly conserved both at the structure (100%) and sequence (80%) levels. Cluster 1 in this family is represented in all structures, although it shows no sign of sequence conservation. In the solved structure, it appears close to the location of a ligand referred to as a crystallization artifact . Moreover, while the active-site-matching cluster shows a strong average electrostatic potential of -7.89 kT/e, cluster 1 presents a much more neutral average value of -1.23 kT/e. Cluster 3 presents also high levels of structural conservation (80%) and, in addition, of sequence level conservation (75%). Both clusters 1 and 3 would be interesting candidates for virtual screening in the search for an allosteric effector ligand.
On the large-scale perspective, the large amounts of putative allosteric sites we have counted may be an overestimation. Many of these cases may represent pockets that are merely the consequence of structural or functional requirements in other regions of the protein. It would be interesting to test for functional links between these regions [8, 11]. However, many protein families do not necessarily perform functions that are associated to a certain pocket, such as the ADP Ribosylation factor discussed above. In these cases, it would not be necessary to find a pair of conserved pockets at a certain distance, since the regulatory site may be a pocket while the protein activity itself may not take place via such a structural feature.
We have developed a simple methodology to estimate the structural conservation of protein pockets, based on their position and size, and have applied it to the large amount of publicly available structural data, covering 4,258 distinct protein families and 22,312 protein structures. The analysis reported here indicates that the presence of structurally conserved pockets is a common feature across protein families and, in some cases, is accompanied by distinctive pocket characteristics in terms of sequence conservation, flexibility or electrostatic potential. Although correlations between the latter properties and structural conservation appear to be low in general, there is, as expected, a higher correlation between pocket structure and sequence conservation for active sites than for other types of annotated or putative ligand-binding pockets. Conserved pockets that lack annotation may represent new opportunities for drug discovery approaches such as virtual screening. In antimicrobial-discovery projects, for example, knowledge of the extent to which a putative ligand-binding site is present across a given protein family (i.e. orthologous proteins in a range of species or genuses) can be applied to the design of broad-spectrum drugs, as well as in dealing with drug toxicity, given that an ideal binding site for an antimicrobial would be present in proteins across many pathogenic species but not in a human homolog. In turn, additional pocket properties such as those considered here may be used for fine selection among pockets with the required level of structural conservation. Thus, we have shown specific examples illustrating that sequence conservation and electrostatic potential may be in some instances used to distinguish active sites from allosteric sites, the latter having a lower sequence-conservation signal and a more neutral potential in these examples. The data generated in this study is available upon request.
Structural data set
We organized the large number of structures available at the Protein Data Bank (PDB)  in protein families by querying all protein sequences, derived from the atomic coordinates of PDB entries, against the Pfam database (release 23.0) . We performed all sequence-based queries by means of the HMMER software suite .
To ensure the quality of the structural data and its relevance to our study, we applied a set of filtering criteria. We evaluated the stereochemistry of protein structures using the PROCHECK program  and removed from our data set entries with a G-Factor value lower than -1.00. In the case of structures solved by crystallographic techniques, we also required a resolution of at least 3.0 Å. Entries not solved by Nuclear Magnetic Resonance (NMR) lacking a resolution value were discarded, independently of the technique used. We also discarded Pfam entries of type 'Motif' or 'Repeat', keeping only types 'Family' and 'Domain' that were assigned to structural regions spanning at least 30 residues.
All structures in our data set were parsed and organized according to the Pfam entry they were assigned to. However, given the bias present in the PDB , a protein family would be poorly represented by a redundant set containing all related structures. To partially remediate this, we clustered the structures in each Pfam entry according to sequence identity (95%) using complete-linkage hierarchical clustering. For each of the obtained clusters, the structure with the best resolution was chosen as the group representative.
Predicting ligand-binding pockets at the protein-family level
To compare the spatial positions of potential ligand-binding pockets in different structures of the same protein family, we first superimposed the representative structures to a common reference by means of the MAMMOTH program . The protein with the longest sequence in the family was taken as reference for the structural fit. If length alone failed to select a single reference structure, we used resolution as the second selection parameter.
We proceeded to predict putative ligand-binding pockets on the fitted structures using the LIGSITEcs program . Residues were assigned to pockets according to a common distance criterion, which includes all residues within 8 Å of the pre-calculated pocket's center of mass . Note that the standalone version of the LIGSITEcs program we used is different from the LIGSITEcsc version also mentioned in , as the former does not incorporate residue conservation as a parameter.
At this point, for each protein family we had a group of superimposed representative protein structures for which the location of putative ligand-binding pockets had been predicted. We then grouped together pockets found consistently in the same position in different representative structures of the same protein family using the clustering method described below. The calculated clusters were finally ranked according to the average size of their member pockets and the percentage number of family representatives featuring the pocket (coverage).
Clustering of pockets
We clustered putative ligand-binding pockets found in different representative structures, previously superimposed, of a protein family using a modified version of a previously described clustering algorithm . In this case, the elements to cluster are the centers of mass of pockets and the metric used to define distances between elements is the Euclidean distance. The clustering algorithm makes no distinction between pockets belonging to different, superimposed structures or to the same structure. Given that the degree of structural diversity among representatives of a protein family varies across protein families, the threshold to the metric for the definition of neighbor elements was chosen to be family specific, as described in the Results section. Unlike the previous implementation of the algorithm, cluster selection is not made by straight neighbor counting but by the sum of neighbor pocket sizes, as predicted by LIGSITEcs .
where m is the total number of representative structures for the corresponding protein family and n r is the number of representative structures with at least one pocket present in the cluster.
There are multiple methods to estimate sequence conservation starting from a multiple sequence alignment (MSA) . We estimated the degree of positional conservation for every residue in our structure data set by the following procedure: (1) We aligned all sequences in the Pfam 'full' MSA  using the HMMALIGN program  and the corresponding HMM profile. (2) We computed the entropy of each position of the alignment by means of the AL2CO program , activating the program option that weights each sequence to partially compensate MSA composition bias . (3) The entropy values for each position in the MSA were inverted (higher score means higher degree of conservation) and normalized by the observed standard deviation. (4) For each Pfam entry we stored the conservation scores obtained using the HMM profile positions as a reference. (5) We aligned each of our structures to the corresponding HMM profile and assigned the previously computed conservation scores to each residue.
To test if a pocket was significantly conserved at the sequence level, we compared the sequence conservation values obtained for all the residues within 8 Å of the center of mass of the pocket with those for all residues in the structure by applying the Wilcoxon-Mann-Whitney non-parametric test. We defined as significant those cases where the p-value <= 0.05.
We estimated the electrostatic protential at the center of mass of the protein ligand-binding pockets by means of the DELPHI software suite , which provides finite-difference solutions to the Poisson-Boltzmann equation. First, we added hydrogen atoms to each structure in our data set using the REDUCE program , then proceeded to estimate the electrostatic potential by means of the DELPHI program, with default parameters.
Protein backbone flexibility
where < B > is the average over all Cα atoms in the structure and σ (B) is the standard deviation. We then define a residue's relative backbone flexibility as the B' value of its Cα.
We tested for pockets that differed significantly from the complete structures in terms of their flexibility. For each pocket in each structure, we compared the values obtained for residues within 8 Å of the center of mass of the pocket to those for all residues in the structure by applying the Wilcoxon-Mann-Whitney non-parametric test. If the values for the pocket were significantly higher, we marked the pocket as 'flexible' and if they were significantly lower, we marked the pocket as 'rigid'. We defined as significant those cases where the p-value <= 0.05.
Mapping active site residues to pockets
Active-site residue predictions by Pfam  usually involve between one and three residues. We combined this sequence level information with the structural prediction of pockets on protein structures by mapping active sites to predicted pockets. For each structure, we marked as active site the pocket that included the majority of predicted active site residues.
In many cases, more than a single pocket contained one or more active site residues. We marked these cases as ambiguous, to distinguish them from cases where the mapping was unambiguous, i.e. all active site residues contained in a single pocket.
We thank Juan Cedano, Francisco Melo, Amelie Stein, Roberto Mosca, Roland Pache and Dunja Urosev for helpful comments and technical advice. This project is supported by funding under the Seventh Research Framework Programme of the European Union (ref. HEALTH-F3-2009-223101). AP acknowledges the FPU Scholarship from MICINN, Spanish Gov.
- Pardee AB: Regulatory molecular biology. Cell Cycle 2006, 5(8):846–852.View ArticlePubMed
- Hardy JA, Wells JA: Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 2004, 14(6):706–715. 10.1016/j.sbi.2004.10.009View ArticlePubMed
- Cui Q, Karplus M: Allostery and cooperativity revisited. Protein Sci 2008, 17(8):1295–1307. 10.1110/ps.03259908PubMed CentralView ArticlePubMed
- Laskowski RA, Gerick F, Thornton JM: The structural basis of allosteric regulation in proteins. FEBS Lett 2009, 583(11):1692–1698. 10.1016/j.febslet.2009.03.019View ArticlePubMed
- Han Y, Malak H, Chaudhary AG, Chordia MD, Kingston DG, Bane S: Distances between the paclitaxel, colchicine, and exchangeable GTP binding sites on tubulin. Biochemistry 1998, 37(19):6636–6644. 10.1021/bi9719760View ArticlePubMed
- Mitra A, Sept D: Taxol allosterically alters the dynamics of the tubulin dimer and increases the flexibility of microtubules. Biophys J 2008, 95(7):3252–3258. 10.1529/biophysj.108.133884PubMed CentralView ArticlePubMed
- Freire E: Can allosteric regulation be predicted from structure? Proc Natl Acad Sci USA 2000, 97(22):11680–11682. 10.1073/pnas.97.22.11680PubMed CentralView ArticlePubMed
- Lockless SW, Ranganathan R: Evolutionarily conserved pathways of energetic connectivity in protein families. Science 1999, 286(5438):295–299. 10.1126/science.286.5438.295View ArticlePubMed
- Balabin IA, Yang W, Beratan DN: Coarse-grained modeling of allosteric regulation in protein receptors. Proc Natl Acad Sci USA 2009, 106(34):14253–14258. 10.1073/pnas.0901811106PubMed CentralView ArticlePubMed
- Kidd BA, Baker D, Thomas WE: Computation of conformational coupling in allosteric proteins. PLoS Comput Biol 2009, 5(8):e1000484. 10.1371/journal.pcbi.1000484PubMed CentralView ArticlePubMed
- Daily MD, Gray JJ: Allosteric communication occurs via networks of tertiary and quaternary motions in proteins. PLoS Comput Biol 2009, 5(2):e1000293. 10.1371/journal.pcbi.1000293PubMed CentralView ArticlePubMed
- Hardy JA, Lam J, Nguyen JT, O'Brien T, Wells JA: Discovery of an allosteric site in the caspases. Proc Natl Acad Sci USA 2004, 101(34):12461–12466. 10.1073/pnas.0404781101PubMed CentralView ArticlePubMed
- Morita K, Kawana K, Sodeyama M, Shimomura I, Kagechika H, Makishima M: Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1. Biochem Pharmacol 2005, 71(1–2):98–107. 10.1016/j.bcp.2005.10.017View ArticlePubMed
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000, 28: 235–242. 10.1093/nar/28.1.235PubMed CentralView ArticlePubMed
- Stuart AC, Ilyin VA, Sali A: LigBase: a database of families of aligned ligand binding sites in known protein sequences and structures. Bioinformatics 2002, 18: 200–201. 10.1093/bioinformatics/18.1.200View ArticlePubMed
- Marti-Renom MA, Rossi A, Al-Shahrour F, Davis FP, Pieper U, Dopazo J, Sali A: The AnnoLite and AnnoLyze programs for comparative annotation of protein structures. BMC Bioinformatics 2007, 8(Suppl 4):S4. 10.1186/1471-2105-8-S4-S4PubMed CentralView ArticlePubMed
- Brady GP, Stouten PF: Fast prediction and visualization of protein binding pockets with PASS. J Comput Aided Mol Des 2000, 14(4):383–401. 10.1023/A:1008124202956View ArticlePubMed
- Glaser F, Morris RJ, Najmanovich RJ, Laskowski RA, Thornton JM: A method for localizing ligand binding pockets in protein structures. Proteins 2006, 62(2):479–488. 10.1002/prot.20769View ArticlePubMed
- Huang B, Schroeder M: LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation. BMC Struct Biol 2006, 6: 19. 10.1186/1472-6807-6-19PubMed CentralView ArticlePubMed
- Huang B: MetaPocket: a meta approach to improve protein ligand binding site prediction. OMICS 2009, 13(4):325–330. 10.1089/omi.2009.0045View ArticlePubMed
- Bartlett GJ, Porter CT, Borkakoti N, Thornton JM: Analysis of catalytic residues in enzyme active sites. J Mol Biol 2002, 324: 105–121. 10.1016/S0022-2836(02)01036-7View ArticlePubMed
- Yuan Z, Zhao J, Wang ZX: Flexibility analysis of enzyme active sites by crystallographic temperature factors. Protein Eng 2003, 16(2):109–114. 10.1093/proeng/gzg014View ArticlePubMed
- Nicola G, Smith CA, Abagyan R: New method for the assessment of all drug-like pockets across a structural genome. J Comput Biol 2008, 15(3):231–240. 10.1089/cmb.2007.0178PubMed CentralView ArticlePubMed
- Bate P, Warwicker J: Enzyme/non-enzyme discrimination and prediction of enzyme active site location using charge-based methods. J Mol Biol 2004, 340(2):263–276. 10.1016/j.jmb.2004.04.070View ArticlePubMed
- Chothia C, Lesk AM: The relation between the divergence of sequence and structure in proteins. EMBO J 1986, 5(4):823–826.PubMed CentralPubMed
- Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, Hotz HR, Ceric G, Forslund K, Eddy SR, Sonnhammer ELL, Bateman A: The Pfam protein families database. Nucleic Acids Res 2008, (36 Database):D281-D288.
- Porter CT, Bartlett GJ, Thornton JM: The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 2004, (32 Database):D129-D133. 10.1093/nar/gkh028
- Xie L, Bourne PE: Functional coverage of the human genome by existing structures, structural genomics targets, and homology models. PLoS Comput Biol 2005, 1(3):e31. 10.1371/journal.pcbi.0010031PubMed CentralView ArticlePubMed
- Ortiz AR, Strauss CEM, Olmea O: MAMMOTH (matching molecular models obtained from theory): an automated method for model comparison. Protein Sci 2002, 11(11):2606–2621. 10.1110/ps.0215902PubMed CentralView ArticlePubMed
- Pei J, Grishin NV: AL2CO: calculation of positional conservation in a protein sequence alignment. Bioinformatics 2001, 17(8):700–712. 10.1093/bioinformatics/17.8.700View ArticlePubMed
- Iwata S, Kamata K, Yoshida S, Minowa T, Ohta T: T and R states in the crystals of bacterial L-lactate dehydrogenase reveal the mechanism for allosteric control. Nat Struct Biol 1994, 1(3):176–185. 10.1038/nsb0394-176View ArticlePubMed
- Teague SJ: Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003, 2(7):527–541. 10.1038/nrd1129View ArticlePubMed
- Daily MD, Gray JJ: Local motions in a benchmark of allosteric proteins. Proteins 2007, 67(2):385–399. 10.1002/prot.21300View ArticlePubMed
- Carlson HA: Protein flexibility and drug design: how to hit a moving target. Curr Opin Chem Biol 2002, 6(4):447–452. 10.1016/S1367-5931(02)00341-1View ArticlePubMed
- Rocchia W, Sridharan S, Nicholls A, Alexov E, Chiabrera A, Honig B: Rapid grid-based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: applications to the molecular systems and geometric objects. J Comput Chem 2002, 23: 128–137. 10.1002/jcc.1161View ArticlePubMed
- Garvie EI: Bacterial lactate dehydrogenases. Microbiol Rev 1980, 44: 106–139.PubMed CentralPubMed
- Amor JC, Harrison DH, Kahn RA, Ringe D: Structure of the human ADP-ribosylation factor 1 complexed with GDP. Nature 1994, 372(6507):704–708. 10.1038/372704a0View ArticlePubMed
- Mistry J, Bateman A, Finn RD: Predicting active site residue annotations in the Pfam database. BMC Bioinformatics 2007, 8: 298. 10.1186/1471-2105-8-298PubMed CentralView ArticlePubMed
- McCarthy AA, Peterson NA, Knijff R, Baker EN: Crystal structure of MshB from Mycobacterium tuberculosis, a deacetylase involved in mycothiol biosynthesis. J Mol Biol 2004, 335(4):1131–1141. 10.1016/j.jmb.2003.11.034View ArticlePubMed
- Eddy SR: Profile hidden Markov models. Bioinformatics 1998, 14(9):755–763. 10.1093/bioinformatics/14.9.755View ArticlePubMed
- Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM: AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996, 8(4):477–486. 10.1007/BF00228148View ArticlePubMed
- Daura X, Gademann K, Jaun B, Seebach D, van Gunsteren WF, Mark AE: Peptide Folding: When Simulation Meets Experiment. Angewandte Chemie International Edition 1999, 38(1–2):236–240. Publisher Full Text 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-MView Article
- Henikoff S, Henikoff JG: Position-based sequence weights. J Mol Biol 1994, 243(4):574–578. 10.1016/0022-2836(94)90032-9View ArticlePubMed
- Word JM, Lovell SC, Richardson JS, Richardson DC: Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J Mol Biol 1999, 285(4):1735–1747. 10.1006/jmbi.1998.2401View ArticlePubMed
- Carugo O, Argos P: Accessibility to internal cavities and ligand binding sites monitored by protein crystallographic thermal factors. Proteins 1998, 31(2):201–213. Publisher Full Text 10.1002/(SICI)1097-0134(19980501)31:2<201::AID-PROT9>3.0.CO;2-OView ArticlePubMed
- Wilmanns M, Nilges M: Molecular replacement with NMR models using distance-derived pseudo B factors. Acta Crystallogr D Biol Crystallogr 1996, 52(Pt 5):973–982. 10.1107/S0907444996003393View ArticlePubMed
- Willis BTM, Pryor AW: Thermal vibrations in crystallography. Cambridge University Press; 1975.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.